Blood, ISSN 0006-4971, 2014, Volume 124, Issue 3, pp. 319 - 327
We assessed risk, localization, and timing of third malignancies in Hodgkin lymphoma (HL) survivors. In a cohort of 3122 5-year HL survivors diagnosed before...
BREAST-CANCER | LONG-TERM SURVIVORS | CHILDHOOD-CANCER | PROPORTIONAL HAZARDS MODEL | PROGNOSTIC-FACTORS | CLINICAL STAGE-I | HEMATOLOGY | STOMACH-CANCER | 2ND MALIGNANCY | SUBSEQUENT NEOPLASMS | RADIATION-THERAPY | Education, Medical, Continuing | Age Factors | Follow-Up Studies | Humans | Middle Aged | Netherlands - epidemiology | Risk Factors | Male | Incidence | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Young Adult | Neoplasms, Second Primary - therapy | Hodgkin Disease - therapy | Adult | Female | Cohort Studies
BREAST-CANCER | LONG-TERM SURVIVORS | CHILDHOOD-CANCER | PROPORTIONAL HAZARDS MODEL | PROGNOSTIC-FACTORS | CLINICAL STAGE-I | HEMATOLOGY | STOMACH-CANCER | 2ND MALIGNANCY | SUBSEQUENT NEOPLASMS | RADIATION-THERAPY | Education, Medical, Continuing | Age Factors | Follow-Up Studies | Humans | Middle Aged | Netherlands - epidemiology | Risk Factors | Male | Incidence | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Young Adult | Neoplasms, Second Primary - therapy | Hodgkin Disease - therapy | Adult | Female | Cohort Studies
Journal Article
Cancer, ISSN 0008-543X, 01/2015, Volume 121, Issue 2, pp. 259 - 268
BACKGROUND Thyroid cancer affects relatively young adults, and its overall survival is excellent. With long life expectancy, the development of subsequent...
second malignancy | thyroid neoplasm | risk | adult | Republic of Korea | Adult | Risk | Second malignancy | Thyroid neoplasm | INCREASING INCIDENCE | SUSCEPTIBILITY | TRENDS | 2ND PRIMARY MALIGNANCY | POLYMORPHISMS | ONCOLOGY | URINARY IODINE EXCRETION | MUTATION | CARCINOMA | ASSOCIATION | SURVIVORS | Thyroid Neoplasms - diagnosis | Thyroid Neoplasms - mortality | Risk Assessment | Humans | Middle Aged | Risk Factors | Survivors - statistics & numerical data | Carcinoma - diagnosis | Male | Incidence | Neoplasms, Second Primary - diagnosis | Neoplasms, Second Primary - epidemiology | Time Factors | Carcinoma - epidemiology | Female | Registries | Aged | Odds Ratio | Republic of Korea - epidemiology | Care and treatment | Cohort analysis | Usage | Thyroid cancer | Young adults | Research | Second primary cancer | Health aspects
second malignancy | thyroid neoplasm | risk | adult | Republic of Korea | Adult | Risk | Second malignancy | Thyroid neoplasm | INCREASING INCIDENCE | SUSCEPTIBILITY | TRENDS | 2ND PRIMARY MALIGNANCY | POLYMORPHISMS | ONCOLOGY | URINARY IODINE EXCRETION | MUTATION | CARCINOMA | ASSOCIATION | SURVIVORS | Thyroid Neoplasms - diagnosis | Thyroid Neoplasms - mortality | Risk Assessment | Humans | Middle Aged | Risk Factors | Survivors - statistics & numerical data | Carcinoma - diagnosis | Male | Incidence | Neoplasms, Second Primary - diagnosis | Neoplasms, Second Primary - epidemiology | Time Factors | Carcinoma - epidemiology | Female | Registries | Aged | Odds Ratio | Republic of Korea - epidemiology | Care and treatment | Cohort analysis | Usage | Thyroid cancer | Young adults | Research | Second primary cancer | Health aspects
Journal Article
Seminars in Oncology, ISSN 0093-7754, 2004, Volume 31, Issue 2, pp. 264 - 273
As the incidence and prevalence of cancer increase with age, it is reasonable to expect that the incidence and prevalence of multiple primary malignancies will...
BREAST-CANCER | PRIMARY TUMORS | WOMEN | NEOPLASMS | ONCOLOGY | 2ND PRIMARY CANCERS | RISK | LYMPHOMA | EXPERIENCE | RENAL-CELL CARCINOMA | EPIDEMIOLOGY | Aged | Aging - physiology | Neoplasms, Multiple Primary - epidemiology | Cell Transformation, Neoplastic | Humans | Risk Factors
BREAST-CANCER | PRIMARY TUMORS | WOMEN | NEOPLASMS | ONCOLOGY | 2ND PRIMARY CANCERS | RISK | LYMPHOMA | EXPERIENCE | RENAL-CELL CARCINOMA | EPIDEMIOLOGY | Aged | Aging - physiology | Neoplasms, Multiple Primary - epidemiology | Cell Transformation, Neoplastic | Humans | Risk Factors
Journal Article
Cancer Epidemiology Biomarkers and Prevention, ISSN 1055-9965, 2014, Volume 23, Issue 3, pp. 490 - 498
Background: Conflicting evidence exists about whether people with a history of nonmelanoma skin cancer (NMSC) are at higher risk of subsequent primary...
DIAGNOSIS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ORGAN TRANSPLANT RECIPIENTS | METAANALYSIS | MANAGEMENT | ONCOLOGY | 2ND PRIMARY CANCERS | PROSTATE-CANCER | SQUAMOUS-CELL CARCINOMA | PHENOTYPE | RISK | KIDNEY | Humans | Middle Aged | Risk Factors | Child, Preschool | Infant | Male | Treatment Outcome | Skin Neoplasms - epidemiology | Neoplasms, Second Primary - epidemiology | Young Adult | England - epidemiology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Child | Infant, Newborn | Cohort Studies
DIAGNOSIS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ORGAN TRANSPLANT RECIPIENTS | METAANALYSIS | MANAGEMENT | ONCOLOGY | 2ND PRIMARY CANCERS | PROSTATE-CANCER | SQUAMOUS-CELL CARCINOMA | PHENOTYPE | RISK | KIDNEY | Humans | Middle Aged | Risk Factors | Child, Preschool | Infant | Male | Treatment Outcome | Skin Neoplasms - epidemiology | Neoplasms, Second Primary - epidemiology | Young Adult | England - epidemiology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Child | Infant, Newborn | Cohort Studies
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2018, Volume 36, Issue 18, pp. 1885 - 1886
Journal Article
JOURNAL OF THORACIC DISEASE, ISSN 2072-1439, 08/2019, Volume 11, Issue 8, pp. 3292 - 3301
Background: Patients with esophageal cancer (EC) frequently have multiple primary cancers. We conducted the present study to assess the risk of multiple...
Esophageal cancer (EC) | LYMPH-NODE DISSECTION | MORTALITY | HEAD | multiple primary cancer | RISK | SMOKING | 2ND CANCERS | ESOPHAGECTOMY | PRIMARY CANCERS | standardized incidence ratios (SIRs) | RESPIRATORY SYSTEM | EPIDEMIOLOGY | Original
Esophageal cancer (EC) | LYMPH-NODE DISSECTION | MORTALITY | HEAD | multiple primary cancer | RISK | SMOKING | 2ND CANCERS | ESOPHAGECTOMY | PRIMARY CANCERS | standardized incidence ratios (SIRs) | RESPIRATORY SYSTEM | EPIDEMIOLOGY | Original
Journal Article
Oncotarget, ISSN 1949-2553, 08/2016, Volume 7, Issue 32, pp. 52450 - 52459
Background: Clinical experiences suggest that breast cancer (BC) and thyroid cancer (TC) occur metachronously or synchronously in a patient more frequently...
Breast cancer | Double primary malignancies | Prognosis | Thyroid cancer | Clinicopathologic characteristics | double primary malignancies | METAANALYSIS | CLINICAL ONCOLOGY/COLLEGE | breast cancer | RISK | thyroid cancer | prognosis | CELL BIOLOGY | WOMEN | 2ND PRIMARY MALIGNANCY | RECOMMENDATIONS | GROWTH | clinicopathologic characteristics | ESTROGEN | RECEPTORS | AMERICAN SOCIETY | Humans | Middle Aged | Thyroid Neoplasms - epidemiology | Neoplasms, Multiple Primary - epidemiology | Case-Control Studies | Incidence | Neoplasms, Second Primary - epidemiology | Breast Neoplasms - pathology | Adult | Female | Aged | Retrospective Studies | Breast Neoplasms - epidemiology | Thyroid Neoplasms - pathology
Breast cancer | Double primary malignancies | Prognosis | Thyroid cancer | Clinicopathologic characteristics | double primary malignancies | METAANALYSIS | CLINICAL ONCOLOGY/COLLEGE | breast cancer | RISK | thyroid cancer | prognosis | CELL BIOLOGY | WOMEN | 2ND PRIMARY MALIGNANCY | RECOMMENDATIONS | GROWTH | clinicopathologic characteristics | ESTROGEN | RECEPTORS | AMERICAN SOCIETY | Humans | Middle Aged | Thyroid Neoplasms - epidemiology | Neoplasms, Multiple Primary - epidemiology | Case-Control Studies | Incidence | Neoplasms, Second Primary - epidemiology | Breast Neoplasms - pathology | Adult | Female | Aged | Retrospective Studies | Breast Neoplasms - epidemiology | Thyroid Neoplasms - pathology
Journal Article
Medicine (United States), ISSN 0025-7974, 2015, Volume 94, Issue 43, p. e1803
To evaluate the risk of secondary primary malignancy (SPM) in patients with cervical cancer using a nationwide population-based dataset.Patients newly...
UTERINE CERVIX | WOMEN | MEDICINE, GENERAL & INTERNAL | LONG-TERM SURVIVORS | 2ND PRIMARY-CANCER | SQUAMOUS-CELL CARCINOMA | RADIOTHERAPY | STOMACH-CANCER | CHEMOTHERAPY | PAPILLOMAVIRUS-ASSOCIATED HEAD | RADIATION-THERAPY | Comorbidity | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Radiotherapy - adverse effects | Neoplasms, Second Primary - epidemiology | Carboplatin - adverse effects | Young Adult | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Neoplasms, Second Primary - chemically induced | Taiwan - epidemiology | Adult | Female | Registries | Aged | Uterine Cervical Neoplasms - therapy | Carcinoid | Research | Diagnosis | Cervical cancer | Risk factors
UTERINE CERVIX | WOMEN | MEDICINE, GENERAL & INTERNAL | LONG-TERM SURVIVORS | 2ND PRIMARY-CANCER | SQUAMOUS-CELL CARCINOMA | RADIOTHERAPY | STOMACH-CANCER | CHEMOTHERAPY | PAPILLOMAVIRUS-ASSOCIATED HEAD | RADIATION-THERAPY | Comorbidity | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Radiotherapy - adverse effects | Neoplasms, Second Primary - epidemiology | Carboplatin - adverse effects | Young Adult | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Neoplasms, Second Primary - chemically induced | Taiwan - epidemiology | Adult | Female | Registries | Aged | Uterine Cervical Neoplasms - therapy | Carcinoid | Research | Diagnosis | Cervical cancer | Risk factors
Journal Article
9.
Full Text
Breast cancer risk factors and second primary malignancies among women with breast cancer
Breast Cancer Research and Treatment, ISSN 0167-6806, 10/2007, Volume 105, Issue 2, pp. 195 - 207
To examine the association between breast cancer risk factors and second primary cancers (independent diagnoses occurring at least 12 months after the initial...
Body mass index | Body height | Medicine & Public Health | Second primary | Body weight | Alcoholic beverages | Oncology | Breast neoplasms | Weight gain | Neoplasms | UNITED-STATES | TAMOXIFEN USE | breast neoplasms | body mass index | 2ND PRIMARY CANCERS | weight gain | ORAL-CONTRACEPTIVE USE | second primary | body height | alcoholic beverages | ENDOMETRIAL CANCER | body weight | CONTRALATERAL BREAST | ONCOLOGY | COLORECTAL-CANCER | REPRODUCTIVE FACTORS | ESTROGEN | neoplasms | YOUNG-WOMEN | Body Mass Index | Colorectal Neoplasms - epidemiology | Reproducibility of Results | Ovarian Neoplasms - diagnosis | Humans | Middle Aged | Risk Factors | Survivors | Endometrial Neoplasms - epidemiology | Endometrial Neoplasms - diagnosis | Colorectal Neoplasms - diagnosis | Neoplasms, Second Primary - diagnosis | Neoplasms, Second Primary - epidemiology | Ovarian Neoplasms - epidemiology | Breast Neoplasms - pathology | Adolescent | Adult | Female | Aged | Weight Gain | Breast Neoplasms - epidemiology
Body mass index | Body height | Medicine & Public Health | Second primary | Body weight | Alcoholic beverages | Oncology | Breast neoplasms | Weight gain | Neoplasms | UNITED-STATES | TAMOXIFEN USE | breast neoplasms | body mass index | 2ND PRIMARY CANCERS | weight gain | ORAL-CONTRACEPTIVE USE | second primary | body height | alcoholic beverages | ENDOMETRIAL CANCER | body weight | CONTRALATERAL BREAST | ONCOLOGY | COLORECTAL-CANCER | REPRODUCTIVE FACTORS | ESTROGEN | neoplasms | YOUNG-WOMEN | Body Mass Index | Colorectal Neoplasms - epidemiology | Reproducibility of Results | Ovarian Neoplasms - diagnosis | Humans | Middle Aged | Risk Factors | Survivors | Endometrial Neoplasms - epidemiology | Endometrial Neoplasms - diagnosis | Colorectal Neoplasms - diagnosis | Neoplasms, Second Primary - diagnosis | Neoplasms, Second Primary - epidemiology | Ovarian Neoplasms - epidemiology | Breast Neoplasms - pathology | Adolescent | Adult | Female | Aged | Weight Gain | Breast Neoplasms - epidemiology
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 11/2015, Volume 56, Issue 11, pp. 3012 - 3021
The development of a secondary primary malignancy (SPM) has become an important issue in myeloma management, given the remarkable improvement in survival...
Secondary malignancies | multiple myeloma | lenalidomide | LENALIDOMIDE PLUS DEXAMETHASONE | CANCER SURVIVORS | ACUTE-LEUKEMIA | MAINTENANCE | ONCOLOGY | 2ND PRIMARY MALIGNANCIES | STEM-CELL TRANSPLANTATION | HEMATOLOGY | MELPHALAN | MDS | Recurrence | Lenalidomide | Risk Assessment | Humans | Risk Factors | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Risk | Treatment Outcome | Antineoplastic Agents - therapeutic use | Thalidomide - pharmacology | Combined Modality Therapy - adverse effects | Incidence | Neoplasms, Second Primary - diagnosis | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Retreatment | Thalidomide - analogs & derivatives | Multiple Myeloma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antineoplastic Agents - pharmacology | Combined Modality Therapy - methods | Thalidomide - therapeutic use
Secondary malignancies | multiple myeloma | lenalidomide | LENALIDOMIDE PLUS DEXAMETHASONE | CANCER SURVIVORS | ACUTE-LEUKEMIA | MAINTENANCE | ONCOLOGY | 2ND PRIMARY MALIGNANCIES | STEM-CELL TRANSPLANTATION | HEMATOLOGY | MELPHALAN | MDS | Recurrence | Lenalidomide | Risk Assessment | Humans | Risk Factors | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Risk | Treatment Outcome | Antineoplastic Agents - therapeutic use | Thalidomide - pharmacology | Combined Modality Therapy - adverse effects | Incidence | Neoplasms, Second Primary - diagnosis | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Retreatment | Thalidomide - analogs & derivatives | Multiple Myeloma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antineoplastic Agents - pharmacology | Combined Modality Therapy - methods | Thalidomide - therapeutic use
Journal Article
Medicine (United States), ISSN 0025-7974, 09/2015, Volume 94, Issue 38, p. e1626
To evaluate the incidence of secondary primary malignancy (SPM) in patients with ovarian cancer using a nationwide retrospective population-based...
BREAST-CANCER | MEDICINE, GENERAL & INTERNAL | BRCA2 MUTATIONS | HODGKINS-DISEASE | NEOPLASMS | GASTRIC-CANCER | COLORECTAL-CANCER | MULTIPLE PRIMARY CANCERS | GERMLINE MUTATIONS | COHORT | 2ND PRIMARY MALIGNANCIES | Risk Assessment | Comorbidity | Humans | Middle Aged | Radiotherapy - adverse effects | Ovarian Neoplasms - radiotherapy | Incidence | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Ovarian Neoplasms - epidemiology | Young Adult | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Taiwan - epidemiology | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Ovarian Neoplasms - drug therapy | Complications and side effects | Research | Second primary cancer | Analysis | Risk factors | Ovarian cancer
BREAST-CANCER | MEDICINE, GENERAL & INTERNAL | BRCA2 MUTATIONS | HODGKINS-DISEASE | NEOPLASMS | GASTRIC-CANCER | COLORECTAL-CANCER | MULTIPLE PRIMARY CANCERS | GERMLINE MUTATIONS | COHORT | 2ND PRIMARY MALIGNANCIES | Risk Assessment | Comorbidity | Humans | Middle Aged | Radiotherapy - adverse effects | Ovarian Neoplasms - radiotherapy | Incidence | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Ovarian Neoplasms - epidemiology | Young Adult | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Taiwan - epidemiology | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Ovarian Neoplasms - drug therapy | Complications and side effects | Research | Second primary cancer | Analysis | Risk factors | Ovarian cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, p. e68041
Studies involving second malignancies in patients with multiple myeloma are limited for the Asian population. Using data from population-based insurance...
BREAST-CANCER | UNITED-STATES | NEOPLASMS | INCREASED RISK | MULTIDISCIPLINARY SCIENCES | LEUKEMIA | MELPHALAN | MYELODYSPLASTIC SYNDROMES | 2ND CANCER | EPIDEMIOLOGY | CHEMOTHERAPY | Hematologic Neoplasms - diagnosis | Hematologic Neoplasms - ethnology | Insurance Claim Review - statistics & numerical data | Age Factors | Multiple Myeloma - diagnosis | Neoplasms, Second Primary - ethnology | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Multiple Myeloma - ethnology | Incidence | Neoplasms, Second Primary - diagnosis | Asian Continental Ancestry Group | Time Factors | Registries - statistics & numerical data | Taiwan - epidemiology | Female | Aged | Retrospective Studies | Population Surveillance - methods | Research | Health aspects | Risk factors | Multiple myeloma | Asians | Disease | Leukemia | Dioxins | Population studies | Malignancy | Family medical history | Gender | Males | Medical diagnosis | Cancer therapies | Illnesses | Older people | Population | Trends | Age | Public health | Hematology | Myeloid leukemia | Hazards | Breast cancer | Patients | Medicine | Studies | Hospitals | Statistical models | Biomarkers | Health risk assessment | Females | Tumors
BREAST-CANCER | UNITED-STATES | NEOPLASMS | INCREASED RISK | MULTIDISCIPLINARY SCIENCES | LEUKEMIA | MELPHALAN | MYELODYSPLASTIC SYNDROMES | 2ND CANCER | EPIDEMIOLOGY | CHEMOTHERAPY | Hematologic Neoplasms - diagnosis | Hematologic Neoplasms - ethnology | Insurance Claim Review - statistics & numerical data | Age Factors | Multiple Myeloma - diagnosis | Neoplasms, Second Primary - ethnology | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Multiple Myeloma - ethnology | Incidence | Neoplasms, Second Primary - diagnosis | Asian Continental Ancestry Group | Time Factors | Registries - statistics & numerical data | Taiwan - epidemiology | Female | Aged | Retrospective Studies | Population Surveillance - methods | Research | Health aspects | Risk factors | Multiple myeloma | Asians | Disease | Leukemia | Dioxins | Population studies | Malignancy | Family medical history | Gender | Males | Medical diagnosis | Cancer therapies | Illnesses | Older people | Population | Trends | Age | Public health | Hematology | Myeloid leukemia | Hazards | Breast cancer | Patients | Medicine | Studies | Hospitals | Statistical models | Biomarkers | Health risk assessment | Females | Tumors
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 5/2013, Volume 20, Issue 5, pp. 1514 - 1521
Our purpose was to examine the incidence and impact on survival of other primary malignancies (OPM) outside of the breast in breast cancer patients and to...
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | PRIMARY TUMORS | ONCOLOGY | INCREASED RISK | LUNG-CARCINOMA | FOLLOW-UP | RADIOTHERAPY | ADJUVANT TAMOXIFEN THERAPY | CONSERVATIVE SURGERY | 2ND CANCERS | CHEMOTHERAPY | ENDOMETRIAL CANCER | Age Factors | Humans | Middle Aged | Risk Factors | Genital Neoplasms, Female - epidemiology | Incidence | Neoplasms, Second Primary - epidemiology | Breast Neoplasms - therapy | Young Adult | Gastrointestinal Neoplasms - epidemiology | Lung Neoplasms - epidemiology | Breast Neoplasms - pathology | Mastectomy, Segmental | Aged, 80 and over | Adult | Female | Aged | Chemotherapy, Adjuvant | Neoplasm Staging | Radiotherapy, Adjuvant | Breast Neoplasms - epidemiology | Lumpectomy | Care and treatment | Cancer patients | Chemotherapy | Nuclear radiation | Analysis | Development and progression | Breast cancer | Diagnosis | Radiotherapy | Cancer
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | PRIMARY TUMORS | ONCOLOGY | INCREASED RISK | LUNG-CARCINOMA | FOLLOW-UP | RADIOTHERAPY | ADJUVANT TAMOXIFEN THERAPY | CONSERVATIVE SURGERY | 2ND CANCERS | CHEMOTHERAPY | ENDOMETRIAL CANCER | Age Factors | Humans | Middle Aged | Risk Factors | Genital Neoplasms, Female - epidemiology | Incidence | Neoplasms, Second Primary - epidemiology | Breast Neoplasms - therapy | Young Adult | Gastrointestinal Neoplasms - epidemiology | Lung Neoplasms - epidemiology | Breast Neoplasms - pathology | Mastectomy, Segmental | Aged, 80 and over | Adult | Female | Aged | Chemotherapy, Adjuvant | Neoplasm Staging | Radiotherapy, Adjuvant | Breast Neoplasms - epidemiology | Lumpectomy | Care and treatment | Cancer patients | Chemotherapy | Nuclear radiation | Analysis | Development and progression | Breast cancer | Diagnosis | Radiotherapy | Cancer
Journal Article
OncoTargets and Therapy, ISSN 1178-6930, 03/2017, Volume 10, pp. 1535 - 1548
Background: The site-distribution pattern and relative risk of subsequent primary malignancies (SPMs) in colorectal cancer (CRC) patients remains to be...
SEER | Standard incidence ratio | Colorectal cancer | Multiple primary malignancies | Cancer risk | PRIMARY TUMORS | LYNCH-SYNDROME | colorectal cancer | MANAGEMENT | standard incidence ratio | multiple primary malignancies | GERMLINE VARIANTS | IDENTIFICATION | 2ND PRIMARY | FAMILIAL RISK | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | cancer risk | SURVEILLANCE | PREDISPOSE | ASSOCIATION | Development and progression | Care and treatment | Health aspects | Quality of life | Endocrine system | Multiple myeloma | Metastasis | Medical screening | Epidemiology | Small intestine | Data bases | Studies | Thyroid cancer | Surveillance | Population | Gallbladder | Software | Lymphomas | Health risk assessment | Age | Tumors
SEER | Standard incidence ratio | Colorectal cancer | Multiple primary malignancies | Cancer risk | PRIMARY TUMORS | LYNCH-SYNDROME | colorectal cancer | MANAGEMENT | standard incidence ratio | multiple primary malignancies | GERMLINE VARIANTS | IDENTIFICATION | 2ND PRIMARY | FAMILIAL RISK | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | cancer risk | SURVEILLANCE | PREDISPOSE | ASSOCIATION | Development and progression | Care and treatment | Health aspects | Quality of life | Endocrine system | Multiple myeloma | Metastasis | Medical screening | Epidemiology | Small intestine | Data bases | Studies | Thyroid cancer | Surveillance | Population | Gallbladder | Software | Lymphomas | Health risk assessment | Age | Tumors
Journal Article
European Journal of Surgical Oncology, ISSN 0748-7983, 2013, Volume 40, Issue 3, pp. 338 - 344
Abstract Aims We carried out a large scale study to identify the risk factors for double primary malignancy (DPM) development in gastric cancer patients and to...
Hematology, Oncology and Palliative Medicine | Surgery | Double primary malignancy | Prognosis | Microsatellite instability | Gastric cancer | PROGNOSTIC IMPLICATIONS | SURGERY | PRIMARY TUMORS | UNITED-KINGDOM | NEOPLASMS | 2ND PRIMARY-CANCER | ONCOLOGY | PROJECTIONS | STOMACH | COLORECTUM | CLINICOPATHOLOGICAL FEATURES | Immunohistochemistry | Neoplasms, Multiple Primary - surgery | Colorectal Neoplasms - surgery | Age Factors | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Stomach Neoplasms - pathology | Neoplasm Invasiveness - pathology | Adult | Female | Retrospective Studies | Colorectal Neoplasms - mortality | Neoplasms, Multiple Primary - mortality | Thyroid Neoplasms - surgery | Thyroid Neoplasms - mortality | Risk Assessment | Treatment Outcome | Neoplasms, Multiple Primary - pathology | Disease-Free Survival | Sex Factors | Survival Analysis | Lung Neoplasms - surgery | Aged | Biopsy, Needle | Colorectal Neoplasms - pathology | Neoplasm Staging | Stomach Neoplasms - surgery | Stomach Neoplasms - mortality | Cohort Studies | Thyroid Neoplasms - pathology | Cancer patients | Stomach cancer | Risk factors | Cancer
Hematology, Oncology and Palliative Medicine | Surgery | Double primary malignancy | Prognosis | Microsatellite instability | Gastric cancer | PROGNOSTIC IMPLICATIONS | SURGERY | PRIMARY TUMORS | UNITED-KINGDOM | NEOPLASMS | 2ND PRIMARY-CANCER | ONCOLOGY | PROJECTIONS | STOMACH | COLORECTUM | CLINICOPATHOLOGICAL FEATURES | Immunohistochemistry | Neoplasms, Multiple Primary - surgery | Colorectal Neoplasms - surgery | Age Factors | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Stomach Neoplasms - pathology | Neoplasm Invasiveness - pathology | Adult | Female | Retrospective Studies | Colorectal Neoplasms - mortality | Neoplasms, Multiple Primary - mortality | Thyroid Neoplasms - surgery | Thyroid Neoplasms - mortality | Risk Assessment | Treatment Outcome | Neoplasms, Multiple Primary - pathology | Disease-Free Survival | Sex Factors | Survival Analysis | Lung Neoplasms - surgery | Aged | Biopsy, Needle | Colorectal Neoplasms - pathology | Neoplasm Staging | Stomach Neoplasms - surgery | Stomach Neoplasms - mortality | Cohort Studies | Thyroid Neoplasms - pathology | Cancer patients | Stomach cancer | Risk factors | Cancer
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 1, pp. 127 - 135
Purpose To examine the risk of subsequent primary malignancies (SPMs) in women diagnosed with endometrial cancer. Methods and Materials The National Cancer...
Radiology | Hematology, Oncology and Palliative Medicine | Radiation-induced malignancies | HNPCC | Endometrial cancer | Second primary malignancies | SURGERY | LYNCH-SYNDROME | NONPOLYPOSIS COLORECTAL-CANCER | 2ND PRIMARY CANCERS | RISK | CERVICAL-CANCER | RADIATION-THERAPY | UTERINE | ONCOLOGY | OVARIAN | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | United States - epidemiology | Colonic Neoplasms - genetics | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - epidemiology | Pharyngeal Neoplasms - etiology | Esophageal Neoplasms - epidemiology | Incidence | Vaginal Neoplasms - genetics | Young Adult | Neoplasms, Radiation-Induced - genetics | Endometrial Neoplasms - genetics | Lung Neoplasms - etiology | Aged, 80 and over | Intestine, Small - radiation effects | Bone Neoplasms - genetics | Neoplasms, Second Primary - genetics | Mouth Neoplasms - genetics | SEER Program | Risk Assessment | Vaginal Neoplasms - etiology | Mouth Neoplasms - etiology | Neoplasms, Second Primary - epidemiology | Mouth Neoplasms - epidemiology | Pharyngeal Neoplasms - genetics | Vaginal Neoplasms - epidemiology | Adolescent | Pharyngeal Neoplasms - epidemiology | Endometrial Neoplasms - radiotherapy | Esophageal Neoplasms - etiology | Age Factors | Neoplasms, Radiation-Induced - etiology | Urinary Bladder Neoplasms - genetics | Adult | Female | Intestinal Neoplasms - genetics | Urinary Bladder Neoplasms - epidemiology | Colonic Neoplasms - etiology | Lung Neoplasms - genetics | Urinary Bladder Neoplasms - etiology | Colonic Neoplasms - epidemiology | Intestinal Neoplasms - etiology | Intestinal Neoplasms - epidemiology | Bone Neoplasms - etiology | Neoplasms, Second Primary - etiology | Lung Neoplasms - epidemiology | Esophageal Neoplasms - genetics | Aged | Neoplasms, Radiation-Induced - epidemiology | Genetic aspects | Research | Oncology, Experimental | Cancer | Index Medicus | LARGE INTESTINE | GASTROINTESTINAL TRACT | ORAL CAVITY | ESOPHAGUS | DIGESTIVE SYSTEM | LUNGS | MEDICINE | PHARYNX | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | BLADDER | RADIOTHERAPY | RADIOLOGY | SMALL INTESTINE | NEOPLASMS | UTERUS | INTESTINES | NUCLEAR MEDICINE | FEMALE GENITALS | ORGANS | URINARY TRACT | DISEASES | RESPIRATORY SYSTEM | BRACHYTHERAPY | BODY
Radiology | Hematology, Oncology and Palliative Medicine | Radiation-induced malignancies | HNPCC | Endometrial cancer | Second primary malignancies | SURGERY | LYNCH-SYNDROME | NONPOLYPOSIS COLORECTAL-CANCER | 2ND PRIMARY CANCERS | RISK | CERVICAL-CANCER | RADIATION-THERAPY | UTERINE | ONCOLOGY | OVARIAN | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | United States - epidemiology | Colonic Neoplasms - genetics | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - epidemiology | Pharyngeal Neoplasms - etiology | Esophageal Neoplasms - epidemiology | Incidence | Vaginal Neoplasms - genetics | Young Adult | Neoplasms, Radiation-Induced - genetics | Endometrial Neoplasms - genetics | Lung Neoplasms - etiology | Aged, 80 and over | Intestine, Small - radiation effects | Bone Neoplasms - genetics | Neoplasms, Second Primary - genetics | Mouth Neoplasms - genetics | SEER Program | Risk Assessment | Vaginal Neoplasms - etiology | Mouth Neoplasms - etiology | Neoplasms, Second Primary - epidemiology | Mouth Neoplasms - epidemiology | Pharyngeal Neoplasms - genetics | Vaginal Neoplasms - epidemiology | Adolescent | Pharyngeal Neoplasms - epidemiology | Endometrial Neoplasms - radiotherapy | Esophageal Neoplasms - etiology | Age Factors | Neoplasms, Radiation-Induced - etiology | Urinary Bladder Neoplasms - genetics | Adult | Female | Intestinal Neoplasms - genetics | Urinary Bladder Neoplasms - epidemiology | Colonic Neoplasms - etiology | Lung Neoplasms - genetics | Urinary Bladder Neoplasms - etiology | Colonic Neoplasms - epidemiology | Intestinal Neoplasms - etiology | Intestinal Neoplasms - epidemiology | Bone Neoplasms - etiology | Neoplasms, Second Primary - etiology | Lung Neoplasms - epidemiology | Esophageal Neoplasms - genetics | Aged | Neoplasms, Radiation-Induced - epidemiology | Genetic aspects | Research | Oncology, Experimental | Cancer | Index Medicus | LARGE INTESTINE | GASTROINTESTINAL TRACT | ORAL CAVITY | ESOPHAGUS | DIGESTIVE SYSTEM | LUNGS | MEDICINE | PHARYNX | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | BLADDER | RADIOTHERAPY | RADIOLOGY | SMALL INTESTINE | NEOPLASMS | UTERUS | INTESTINES | NUCLEAR MEDICINE | FEMALE GENITALS | ORGANS | URINARY TRACT | DISEASES | RESPIRATORY SYSTEM | BRACHYTHERAPY | BODY
Journal Article